• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza in Latin America: A report from the Global Influenza Initiative (GII)

tetano

Editor, Senior Moderator
Vaccine. 2019 Apr 8. pii: S0264-410X(19)30436-0. doi: 10.1016/j.vaccine.2019.03.081. [Epub ahead of print]
[h=1]Influenza in Latin America: A report from the Global Influenza Initiative (GII).[/h] Gentile A[SUP]1[/SUP], Paget J[SUP]2[/SUP], Bellei N[SUP]3[/SUP], Torres JP[SUP]4[/SUP], Vazquez C[SUP]5[/SUP], Laguna-Torres VA[SUP]6[/SUP], Plotkin S[SUP]7[/SUP]; GII.
[h=3]Author information[/h]

[h=3]Abstract[/h] The Global Influenza Initiative (GII) is a global expert group that aims to raise acceptance and uptake of influenza vaccines globally and provides recommendations and strategies to address challenges at local, national, regional, and global levels. This article provides a consolidated estimation of disease burden in Latin America, currently lacking in published literature, and delivers the GII recommendations specific to Latin America that provide guidance to combat existing vaccination challenges. While many countries worldwide, especially in the tropics and subtropics, do not have a seasonal influenza policy, 90% of Latin American countries have a seasonal influenza policy in place. Local governments in the Latin American countries and The Pan American Health Organization's Technical Advisory Group on Vaccine-preventable Diseases play a major role in improving the vaccination coverage and reducing the overall disease burden. Influenza seasonality poses the biggest challenge in deciding on optimal timing for vaccination in Latin America, as in temperate climates seasonal influenza activity peaks during the winter months (November-February and May-October) in the northern and southern hemispheres, respectively, while in the tropics and subtropical regions it usually occurs throughout the year, but especially during the rainy season. Besides this, vaccine mismatch with circulating strains, misconception concerning influenza vaccine effectiveness, and poor disease and vaccine awareness among the public are also key challenges that need to be overcome. Standardization of clinical case definitions is important across all Latin American countries. Surveillance (mostly passive) has improved substantially in the Latin American countries over the past decade, but more is still required to better understand the disease burden and help inform policies.
Copyright ? 2019. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Epidemiology; Global Influenza Initiative; Influenza; Latin America; Surveillance; Vaccination

PMID: 30975568 DOI: 10.1016/j.vaccine.2019.03.081
 
Back
Top Bottom